Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode

December 29, 2023 00:24:55
Episode Cover

Should We Intubate For GCS < 8?

Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may...

Listen

Episode 0

December 11, 2019 00:20:17
Episode Cover

Amniotic Fluid Embolism

Amniotic fluid embolism (AFE) is a catastrophic syndrome that occurs very soon after delivery and is a significant cause of morbidity and mortality.  Unfortunately,...

Listen

Episode 0

March 17, 2024 00:22:04
Episode Cover

Steroids in Sepsis, ARDS, and CAP - A Focused Clinical Update

Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.  In recent years, several...

Listen